Reliability of paramagnetic rim lesion detection at 1.5T MRI in multiple sclerosis patients

Maria Sofia Martire1,2, Lucia Moiola3, Pietro Maggi4,5

  • 1Neurology Unit, IRCCS San Raffaele Hospital, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|February 1, 2025
PubMed
Abstract

Insights

Paramagnetic rim lesions (PRL) are reliably detectable on 1.5T MRI scans, similar to 3T scans. This finding supports the clinical use of PRL for multiple sclerosis (MS) diagnosis and prognosis.

Area of Science:

  • Radiology
  • Neuroimaging
  • Magnetic Resonance Imaging (MRI)

Background:

  • Paramagnetic rim lesions (PRL) are crucial biomarkers for multiple sclerosis (MS) diagnosis and prognosis.
  • PRL are currently detectable using 7T and 3T MRI, but their visibility on standard 1.5T scanners needs evaluation for clinical translation.

Purpose of the Study:

  • To assess the reliability of detecting PRL using commercially available susceptibility-weighted imaging (SWI) at 1.5T compared to 3T MRI.
  • To determine if 1.5T MRI can be effectively used for identifying PRL in clinical practice.

Main Methods:

  • SWI images were acquired from 20 individuals with MS at both 1.5T and 3T MRI.
  • Lesions identified at 3T by expert raters using NAIMS criteria served as the reference standard.
  • Four blinded raters assessed PRL visibility at 1.5T, with discrepancies resolved by consensus.

Main Results:

  • Paramagnetic rim lesions (PRL) were identified in 16 out of 20 patients.
  • 82% of PRL detected at 3T were also visible at 1.5T (78 out of 95 PRL).
  • Interrater reliability was "almost perfect" for both 1.5T and 3T scans, and patients were accurately classified regarding the presence of PRL.

Conclusions:

  • The majority of PRL are detectable at 1.5T MRI.
  • Detection of PRL at 1.5T does not significantly reduce specificity or increase pseudo-PRL detection.
  • This supports the potential for wider clinical application of PRL in MS diagnosis and prognosis using 1.5T scanners.